Coty Inc. (COTY) Stock Price & Analysis
Coty Inc. (COTY) closed at USD 3.21 on Thursday, October 22, 2026, up 5.25% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 3.05; the Oct 22, 2026 session ranged USD 3.06–3.22 on volume of 8,575,150 shares. Market capitalization is $2.83B, with a 52-week range of USD 1.82–4.25 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:03 UTC.
Also available as compact Markdown for AI agents: nexqual.com/COTY.md
Key facts (COTY)
- Last four reported quarters (through Jun 30, 2026): revenue $5.81B, net income -$605M (-10.4% margin), free cash flow $348M (SEC filings).
- 2 of 80 tracked superinvestors hold COTY (13F, Q2 2026): 1 new, 0 added, 1 reduced, 0 unchanged.
- Analysts: Hold (mean 3.24 on a 1–5 scale) (17 analysts), mean target USD 2.7 (range 1.5–4).
- Total return with dividends: 1Y -22.1% vs S&P 500 +14.9%; 5Y -60.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.12, revenue estimate $1.53B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (COTY)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.30B | $5.55B | $6.12B | $5.89B | $5.81B | $5.81B |
| Gross profit | $3.37B | $3.55B | $3.94B | $3.82B | $3.65B | — |
| Operating income | $241M | $544M | $547M | $241M | -$81.5M | -$81.5M |
| Net income | $260M | $508M | $89.4M | -$368M | -$605M | -$605M |
| EPS (diluted) | $0.08 | $0.57 | $0.09 | -$0.44 | -$0.70 | — |
| Free cash flow | $553M | $403M | $369M | $278M | $348M | $348M |
| Gross margin | 63.5% | 63.9% | 64.4% | 64.8% | 62.9% | — |
| Operating margin | 4.5% | 9.8% | 8.9% | 4.1% | -1.4% | -1.4% |
| Net margin | 4.9% | 9.1% | 1.5% | -6.2% | -10.4% | -10.4% |
| Revenue growth | +14.6% | +4.7% | +10.2% | -3.7% | -1.5% | — |
| Cash + short-term investments | $233M | $247M | $301M | $257M | $176M | — |
| Total debt | $4.50B | $4.28B | $3.91B | $4.01B | $3.09B | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (COTY)
P/S 0.5x · EV/EBITDA 14.3x · EV/Sales 1.0x · P/FCF 8.1x · P/B 0.9x · FCF yield 12.32% · Earnings yield -21.39% · Net debt $2.91B · EV $5.74B
P/E at fiscal year-ends: Jun 2024 99.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (COTY)
2 of 80 tracked investors hold COTY. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Bill Miller | Miller Value Partners | 2.00% | $8.5M | New position |
| Lee Ainslie | Maverick Capital | 0.02% | $2.2M | Reduced -20.3% |
Analysts (COTY)
Consensus Hold (mean 3.24 on a 1–5 scale), 17 analysts; mean target USD 2.7 (low 1.5, high 4).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Jefferies | Target raised | Buy | $2.4 → $2.95 |
| 2026-10-14 | Citigroup | Target raised | Neutral | $2.8 → $3 |
| 2026-08-25 | Morgan Stanley | Target raised | Equal-Weight | $2.5 → $2.75 |
Total return (dividends reinvested) (COTY)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -22.1% | -60.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -22.1% | -16.8% |
| Volatility (annualized) | 50.6% | 42.6% |
| Max drawdown | -55.3% (Oct 2025→Jun 2026) | -85.3% (Feb 2024→Jun 2026) |
COTY revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Prestige | $771.8M | 60.8% | +1.5% |
| Consumer Beauty | $497.4M | 39.2% | +1.1% |
| Total revenue | $1.27B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
COTY suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Hypermarcas S.A. (HYPMY) | “We may not have adequate or any insurance coverage for some of these legacy matters, including matters assumed in the acquisition of the P&G Beauty Business, the Hypermarcas Brands and the Burberry fragrance business, and the joint venture with Kylie Jenner.” |
Quoted from the company's 10-K filed Aug 20, 2026.
Companies that name COTY in their SEC reports
| Relationship to COTY | Company | Filing | Sentence |
|---|---|---|---|
| supplier | SILGAN HOLDINGS INC (SLGN) | 10-K Feb 26, 2026 | “Our largest customers of our dispensing and specialty closures business include Beiersdorf AG, British American Tobacco AB, Campbell, The Coca-Cola Company, Colgate-Palmolive Company, Coty, Inc., Dairy Farmers of America, Estée Lauder Companies, The Kraft Heinz Company, or Kraft Heinz, L'Oréal S.A., LVMH Moët Hennessy Louis Vuitton, Mizkan Holdings Co., Ltd., Molson Coors Brewing Company, Natura & Co., Nestlé, O B…” |
COTY company outlook (results filed Aug 19, 2026)
- “Coty expects 1Q27 LFL revenue to decline by a low- to mid-single-digit percentage.”
- “While sell-out trends for both divisions are expected to be broadly consistent with the trends in the second half of FY26, the timing of customer orders and prior year comparisons are expected to contribute to fluctuations in year-over-year sales trends.”
- “Adjusted gross margin in 1Q27 is expected to decline by approximately 50 to 100 basis points year-over-year, reflecting cost absorption headwinds from lower shipments, partially offset by productivity initiatives and procurement actions.”
- “Coty anticipates 1Q27 adjusted EBITDA to decline by a low-teens percentage, representing a sequential improvement from the more significant declines in the second half of FY26.”
Quoted word-for-word from the SEC 8-K results press release.
COTY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.12 | $0.14 | -10.3% | $1.53B | 10 |
| Next quarter (ends Dec 2026) | $0.16 | $0.16 | -2.0% | $1.64B | 10 |
| Current fiscal year (ends Jun 2027) | $0.33 | $0.34 | -4.9% | $5.70B | 13 |
| Next fiscal year (ends Jun 2028) | $0.25 | $0.38 | -34.7% | $5.23B | 13 |
COTY options: expected move
Options price a move of about ±17.1% (±$0.55) by Nov 20, 2026, which includes earnings on Nov 4, 2026. Over the last 8 reports the stock moved ±10.2% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 68.2% | ±17.1% |
| Dec 18, 2026 | 56 | 64.4% | ±20.2% |
| Jan 15, 2027 | 84 | 55.6% | ±25.7% |
| Feb 19, 2027 | 119 | 58.3% | ±25.7% |
| May 21, 2027 | 210 | 58.3% | ±33.5% |
30-day implied volatility 61.1% vs 47.3% realized over the last 30 trading days. Put/call ratio (volume) 0.62. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 10:03 UTC)
| Price | USD 3.21 |
|---|---|
| Change | ▲ 5.25% (up) |
| Previous Close | USD 3.05 |
| Open | USD 3.09 |
| Day Range | USD 3.06 – 3.22 |
| 52-Week Range | USD 1.82 – 4.25 |
| Volume | 8,575,150 shares |
| Market Cap | $2.83B |
| Exchange | NYQ |
Technical Analysis (COTY)
Nexqual's technical model rates COTY "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 10:03 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.66 (neutral) |
| vs SMA50 | Above (USD 2.79) |
| MACD | 0.13 (positive) |
Analyst Ratings (COTY)
Wall Street analysts rate COTY "Hold" based on 17 analysts, with a mean price target of USD 2.7 (range USD 1.5–4), per Nexqual as of October 23, 2026 at 10:03 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 2.7 |
| High Target | USD 4 |
| Low Target | USD 1.5 |
| Buy / Hold / Sell | 0 / 15 / 2 |
Earnings (COTY)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.12 |
| Revenue Estimate | $1.53B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.02 vs est -0.01 ▼ miss |
| 2026-03-31 | USD -0.03 vs est -0 ▼ miss |
| 2025-12-31 | USD 0.14 vs est 0.18 ▼ miss |
| 2025-09-30 | USD 0.12 vs est 0.15 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
Financials & Fundamentals (COTY)
| Total Revenue | $5.81B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +1.30% |
| Gross Margin | +62.89% |
| Operating Margin | -2.44% |
| Profit Margin | -10.42% |
| ROE | -16.09% |
| Debt / Equity | 0.98 |
| Current Ratio | 0.76 |
| Total Cash | $176.10M |
| Total Debt | $3.30B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $348.20M (6.0% of revenue) |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
Financial Health Score (COTY)
Nexqual rates Coty Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:03 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 63%, operating -2% (last 12 months) |
| Balance Sheet | Weak — $176M cash and investments vs $3.09B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $348M (last 4 quarters to Jun 2026, SEC), 6% margin |
| Efficiency | Critical — ROE -16%, ROA 1.8% |
Ownership (COTY)
| Insider Ownership | +54.78% |
|---|---|
| Institutional Ownership | +42.56% |
| Shares Outstanding | 880.69M |
| Float | 376.42M |
| Short % of Float | +9.55% |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
From Coty Inc.'s Latest SEC 10-K Filing (filed 2026-08-20)
Key Strengths & Strategy (as disclosed to the SEC)
- A number of our products incorporate patented, patent-pending or proprietary technology.
- A number of our products also incorporate patented, patent-pending or proprietary technology in their respective formulations and/or packaging, and in some cases our product packaging is subject to copyright, trade dress or design protection.
Partnerships
- We collaborate with our suppliers to meet our stringent design and creative criteria.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes in laws, regulations and policies that affect our business or products could adversely affect our business, financial condition, results of operations, cash flows, as well as the trading price of our securities.
- Failure by us or our subsidiaries to comply with applicable laws or policies could subject us to civil and criminal penalties, cause us to be in breach of contract or damage to our or our licensors' reputation, each of which could materially and adversely affect our business, prospects, financial condition, cash flows, results of operations, as well as the trading price of our securities.
- Our employees or others may engage in misconduct or other improper activities including noncompliance with regulatory standards and regulatory requirements.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NWL | Newell Brands Inc. | USD 5.73 | ▲ 3.06% |
| IPAR | Interparfums, Inc. | USD 116.07 | ▲ 2.54% |
| SPB | Spectrum Brands Holdings, Inc. | USD 81.03 | ▲ 2.62% |
| EPC | Edgewell Personal Care Company | USD 28.89 | ▲ 7.08% |
| ELF | e.l.f. Beauty, Inc. | USD 114.99 | ▲ 1.06% |
| ODD | ODDITY Tech Ltd. | USD 23.35 | ▲ 4.33% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:03 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt